ZA994285B - Process for pyrrolidinyl hydroxamic acid compounds. - Google Patents

Process for pyrrolidinyl hydroxamic acid compounds.

Info

Publication number
ZA994285B
ZA994285B ZA9904285A ZA994285A ZA994285B ZA 994285 B ZA994285 B ZA 994285B ZA 9904285 A ZA9904285 A ZA 9904285A ZA 994285 A ZA994285 A ZA 994285A ZA 994285 B ZA994285 B ZA 994285B
Authority
ZA
South Africa
Prior art keywords
acid compounds
hydroxamic acid
pyrrolidinyl
pyrrolidinyl hydroxamic
compounds
Prior art date
Application number
ZA9904285A
Other languages
English (en)
Inventor
Keith Michael Devries
Brian Clement Vanderplas
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA994285B publication Critical patent/ZA994285B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9904285A 1998-08-24 1999-06-30 Process for pyrrolidinyl hydroxamic acid compounds. ZA994285B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9763398P 1998-08-24 1998-08-24

Publications (1)

Publication Number Publication Date
ZA994285B true ZA994285B (en) 2001-01-02

Family

ID=22264376

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9904285A ZA994285B (en) 1998-08-24 1999-06-30 Process for pyrrolidinyl hydroxamic acid compounds.

Country Status (18)

Country Link
US (1) US6031114A (ja)
EP (1) EP0982297A3 (ja)
JP (1) JP3245578B2 (ja)
KR (1) KR100338916B1 (ja)
CN (1) CN1245799A (ja)
AR (1) AR016500A1 (ja)
AU (1) AU4466599A (ja)
BR (1) BR9902525A (ja)
CA (1) CA2277242A1 (ja)
HU (1) HUP9901944A3 (ja)
ID (1) ID23462A (ja)
IL (1) IL130429A0 (ja)
IN (1) IN190844B (ja)
PL (1) PL334144A1 (ja)
RU (1) RU2163235C1 (ja)
TR (1) TR199901546A3 (ja)
YU (1) YU31499A (ja)
ZA (1) ZA994285B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508851A (ja) 2001-04-30 2005-04-07 ファイザー・プロダクツ・インク カッパーアゴニストとして有用なヒドロキシピロリジニルエチルアミン化合物の調製方法
AU2003269399A1 (en) * 2002-11-01 2004-05-25 Pfizer Products Inc. Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
US7744750B2 (en) * 2005-11-17 2010-06-29 Exxonmobil Chemical Patents Inc. Process for reducing Bromine Index of hydrocarbon feedstocks
US8057664B2 (en) * 2005-11-17 2011-11-15 Exxonmobil Chemical Patents, Inc. Process for reducing bromine index of hydrocarbon feedstocks
US7517824B2 (en) * 2005-12-06 2009-04-14 Exxonmobil Chemical Company Process for steam stripping hydrocarbons from a bromine index reduction catalyst

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0132001B1 (ko) * 1994-05-21 1998-04-17 강박광 신규한 치환된 이미다졸 유도체
IL117440A0 (en) * 1995-03-31 1996-07-23 Pfizer Pyrrolidinyl hydroxamic acid compounds and their production process
MX9701042A (es) * 1996-02-07 1998-05-31 Pfizer Compuestos del acido hidroxamico.
TNSN97092A1 (ar) * 1996-09-18 1999-12-31 Agouron Pharma مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة.

Also Published As

Publication number Publication date
IL130429A0 (en) 2000-06-01
EP0982297A3 (en) 2001-08-01
BR9902525A (pt) 2000-05-02
JP3245578B2 (ja) 2002-01-15
KR20000016898A (ko) 2000-03-25
IN190844B (ja) 2003-08-23
HUP9901944A2 (hu) 2000-06-28
RU2163235C1 (ru) 2001-02-20
HU9901944D0 (en) 1999-08-30
KR100338916B1 (ko) 2002-05-30
TR199901546A2 (xx) 2000-04-21
AU4466599A (en) 2000-03-09
HUP9901944A3 (en) 2001-10-29
AR016500A1 (es) 2001-07-04
CN1245799A (zh) 2000-03-01
PL334144A1 (en) 2000-02-28
ID23462A (id) 2000-04-27
TR199901546A3 (tr) 2000-04-21
YU31499A (sh) 2002-11-15
EP0982297A2 (en) 2000-03-01
JP2000072744A (ja) 2000-03-07
US6031114A (en) 2000-02-29
CA2277242A1 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
ZA992629B (en) (4-arylsulfonylamino)-tetrahydropyran-4-caboxylic acid hydroxamides.
AU4579399A (en) Fluoxetine process from benzoylpropionic acid
PL348827A1 (en) Process for making 2,3-dihalopropanols
GB9802027D0 (en) Chemical process
ZA978880B (en) Process for purifying hydroxide compounds.
HK1030610A1 (en) Improved process for antiparaistic agent.
ZA994285B (en) Process for pyrrolidinyl hydroxamic acid compounds.
EA199900284A3 (ru) Способ получения гидроксамовых кислот
ZA992627B (en) Process for alkylating hindered sulfonamides.
SG71899A1 (en) Method for making bis-xylenols containing acid moieties
HUP0100253A3 (en) Process for preparing (r)-2-bromo-3-phenyl-propionic acid
EP1089978A4 (en) METHOD FOR PRODUCING OXIMIDAZOLES
GB9812276D0 (en) Catalytic process
EG22139A (en) Process for preparing 4- substituted-1H-indole -3- glyoxamides
GB9827195D0 (en) Catalytic process
ZA972928B (en) Improved process for pyrimidinone compounds.
GB9806356D0 (en) Hydroxamic acid compounds
GB9914206D0 (en) Chemical process
GB9808619D0 (en) Chemical process
HUP9801978A3 (en) Process for purifying phosphoryl-chloride
EP1119549A4 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-1H-INDOLE-3-GLYOXAMIDES
GB9803264D0 (en) Chemical process
GB9820465D0 (en) Chemical process
GB9827133D0 (en) Chemical process
GB9800200D0 (en) Chemical process